<DOC>
	<DOCNO>NCT01432873</DOCNO>
	<brief_summary>Selenium antioxidant anti-inflammatory agent could effective prevention mucositis induce chemotherapy radiotherapy . Other agent vitamin E , Zinc sulfate , amifostine , beta carotene benzidamine indicate prevention mucositis positive effect see . Our purpose double blind randomize study evaluate selenium effect mucositis prevention patient acute myeloid leukemia ( AML ) &amp; acute lymphoblastic leukemia ( ALL ) whose receive Busulfan and/or Cyclophosphamide Hematopoietic stem cell transplantation ( HSCT ) .</brief_summary>
	<brief_title>Oral Selenium Therapy Prevention Mucositis</brief_title>
	<detailed_description>Patients AML ALL diagnosis , candidate high dose chemotherapy stem cell transplantation screen enrollment study . Patients randomize two group balance block randomization method . One group receive selenium tablet twice per day another group receive placebo two time per day.Therapy start morning start chemotherapy continue first either discharge day day +21 . Response assessment include : 1 . Mucositis assessment use WHO grade OMAS scores- do baseline day +21 discharge day day +21 . 2 . Evaluation selenium glutathione peroxidase level serum , - do baseline , day +7 day +14 . 3 . Collection clinical outcome data regard infectious complication including- presence length febrile neutropenia , use antibacterial antifungal medication</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>Patients AML ALL undergoing high dose chemotherapy stem cell transplantation Adequate renal hepatic function Taking selenium supplement admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>BMT</keyword>
	<keyword>HSCT</keyword>
</DOC>